Cryptogenic organizing pneumonia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Cryptogenic organizing pneumonitis}}
{{Cryptogenic organizing pneumonia}}


{{CMG}}
{{CMG}}
Line 21: Line 21:


[[Category:Disease]]
[[Category:Disease]]
[[Category:Infectious disease]]
[[Category:Pulmonology]]
[[Category:Pulmonology]]

Revision as of 20:05, 1 March 2016

Cryptogenic Organizing Pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cryptogenic organizing pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Electrocardiogram

Ultrasonography/Echocardiography

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cryptogenic organizing pneumonia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cryptogenic organizing pneumonia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cryptogenic organizing pneumonia epidemiology and demographics

CDC on Cryptogenic organizing pneumonia epidemiology and demographics

Cryptogenic organizing pneumonia epidemiology and demographics in the news

Blogs on Cryptogenic organizing pneumonia epidemiology and demographics

Directions to Hospitals Treating Cryptogenic organizing pneumonitis

Risk calculators and risk factors for Cryptogenic organizing pneumonia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Epidemiology and Demographics

Reported incidence is 0.01%, but COP may be more common and underdiagnosed. The mortality rate is approximately 7%, although these tend to be the elderly or those in poor health from other conditions.

Age

It usually begins between the ages of 40 and 60.

Gender

It affects men and women equally.

References